Targeting ceramides and adiponectin receptors in the islet of langerhans for treating diabetes

HIGHLIGHTS

• who: Wen-hong Li from the Departments of Cell Biology and of Biochemistry, University of Texas Southwestern Medical Center have published the research work: Targeting Ceramides and Adiponectin Receptors in the Islet of Langerhans for Treating Diabetes, in the Journal: Molecules 2022, 6117 of /2022/

SUMMARY

In human cells, sphingomyelin is the most abundant form, representing ~85% of all sphingolipids, and typically makes up ~15% of the plasma_membrane lipids. Sphingomyelin is preferentially distributed to the outer leaflet of the eukaryotic plasma_membrane, and plays important roles in maintaining membrane mechanical stability, forming micrometer-scale . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.